Investment Rating - The report maintains an "Accumulate" rating for 康方生物 (9926) [2][4][5]. Core Views - 康方生物's core product, 依沃西, is entering a harvest period with accelerated revenue growth, leading to an upward revision of revenue forecasts for 2024-2026 to 29.24 billion, 47.69 billion, and 65.95 billion RMB respectively [5]. - The clinical data for 依沃西 against K药 shows record results, with an ITT population HR of 0.51, indicating significant benefits across all subgroups [5]. - The safety profile of 依沃西 in squamous cell carcinoma is superior, breaking through the safety limitations of traditional anti-VEGF therapies [5]. - Multiple clinical trials are advancing, with new plans for first-line NSCLC clinical studies announced by Summit [5]. Summary by Sections Clinical Data - 依沃西's clinical trial results show a median progression-free survival (mPFS) of 11.14 months compared to 5.82 months for K药, with a hazard ratio (HR) of 0.51, indicating a 49% reduction in the risk of disease progression or death [5]. - The overall response rate (ORR) for 依沃西 is 50.0% versus 38.5% for K药, and the disease control rate (DCR) is 89.9% compared to 70.5% [5]. - Subgroup analyses show strong positive results for various populations, including HRs of 0.46 for PD-L1 TPS≥50% and 0.48 for squamous carcinoma [5]. Safety Profile - The incidence of grade 3 or higher treatment-related adverse events (TRAE) is comparable between 依沃西 and K药 (22.2% vs 18.7%) [5]. - In squamous cell carcinoma patients, the risk of bleeding is not significantly increased, with a grade 3 or higher adverse event rate of 10.2% for 依沃西 compared to 1.0% for K药 [5]. Financial Projections - Revenue forecasts for 康方生物 have been revised upwards, with expected revenues of 2.924 billion RMB in 2024, 4.769 billion RMB in 2025, and 6.595 billion RMB in 2026, reflecting significant growth [9]. - The company reported a net profit of 2.028 billion RMB in 2023, with projections of -334 million RMB in 2024, followed by a return to profitability in 2025 and 2026 [9].

股 票 研 究 证 券 研 究 报 告 外销贡献增长动能，多数企业注重收入 [Table_Industry] 家用电器业 [Table_Invest] 评级： 增持 上次评级: 增持 ——家电板块 24H1 财报解读 股票研究 /[Table_Date] 2024.09.09 | --- | --- | --- | --- | |----------|-------------------------------------|----------------------------|---------------------------| | | | | | | | [table_Authors] 蔡雯娟 ( 分析师 ) | 曲世强 ( 研究助理 ) | 李汉颖 ( 研究助理 ) | | | 021-38031654 | 021-38031025 | 010-83939833 | | | caiwenjuan024354@gtjas.com | qushiqiang028674@gtjas.com | lihanying026725@gtjas.com | | 登记编号 | S0880521050002 | ...

Investment Rating - Maintains "Buy" rating [4] Core Views - The company released its 2024 interim report, with performance in line with expectations [3] - Revenue for 2024H1 was RMB 13.564 billion, a year-on-year decrease of 11.33%, and net profit was RMB 1.043 billion, a year-on-year decrease of 30.19% [4] - The company is transitioning its pipeline business sales and optimizing its debt structure [2][3] - The company is actively expanding into non-real estate sectors, such as oil and hydrogen pipelines, and the agricultural and rural markets are showing growth trends [4] - The company's gross margin remained stable year-on-year, with the pipeline business gross margin estimated at around 29.5% [4] - The company's debt structure is being optimized, with total debt at the end of 2024H1 at RMB 21.03 billion, a year-on-year decrease of 12.8% [4] Financial Summary - Revenue for 2024H1: RMB 13.564 billion, a year-on-year decrease of 11.33% [4] - Net profit for 2024H1: RMB 1.043 billion, a year-on-year decrease of 30.19% [4] - Gross margin for 2024H1: 27.48%, relatively stable year-on-year [4] - Total debt at the end of 2024H1: RMB 21.03 billion, a year-on-year decrease of 12.8% [4] - Expected net profit for 2024-2026: RMB 2.088 billion, RMB 2.280 billion, and RMB 2.546 billion respectively [4] Market Data - Current stock price: HKD 2.64 [5] - 52-week price range: HKD 2.64 - HKD 4.55 [6] - Current market capitalization: HKD 8.19 billion [6]

Investment Rating - The report assigns a "Cautious Accumulate" rating to the company [3][4]. Core Views - The company's H1 2024 performance met expectations, with continuous progress in both internal and external business operations, as well as rapid growth in overseas business [3]. - The EPS forecasts for 2024 and 2025 have been adjusted to 1.00 and 1.10 CNY respectively, down from 1.08 and 1.25 CNY, while the 2026 EPS forecast is set at 1.20 CNY [3]. - The target price is maintained at 26.29 CNY, reflecting a valuation premium of 20% over comparable companies, corresponding to a PE of 23.90x for 2025 [3]. Financial Performance Summary - For H1 2024, the company achieved revenue of 20.114 billion CNY, a year-on-year increase of 10.02%, and a net profit attributable to shareholders of 2.709 billion CNY, up 8.36% year-on-year [3]. - The company's Q2 2024 revenue reached 12.415 billion CNY, showing a year-on-year growth of 2.99% and a quarter-on-quarter increase of 61.25% [3]. - The company's sales, management, and R&D expense ratios were 4.82%, 3.84%, and 9.20% respectively for H1 2024 [3]. Business Development Summary - The company has made significant strides in both internal and external markets, securing major projects in the domestic market while also expanding its external business [3]. - In H1 2024, the company won several key projects, including the SVG for Tibet's grid construction and various energy management centers [3]. - The overseas revenue reached 0.831 billion CNY, marking a substantial year-on-year growth of 92.8% [3]. Financial Forecast Summary - The financial summary indicates a steady growth trajectory, with projected revenues increasing from 51.573 billion CNY in 2023 to 68.824 billion CNY by 2026, reflecting a compound annual growth rate of approximately 10% [8]. - The net profit attributable to shareholders is expected to rise from 7.184 billion CNY in 2023 to 9.669 billion CNY in 2026 [8]. - The EPS is projected to grow from 0.89 CNY in 2023 to 1.20 CNY in 2026 [8].

股 票 研 究 行 业 周 报 证 券 研 究 报 告 国泰君安版权所有发送给上海东方财富金融数据服务有限公司.东财接收研报邮箱.ybjieshou@eastmoney.com p1 股票研究 /[Table_Date] 2024.09.09 运-20 海外首次飞行展示，美海军将大规模装备星链 [Table_Industry] 军工 [Table_Invest] 评级： 增持 上次评级: 增持 | --- | --- | --- | |----------|-----------------------------------|----------------------------| | | | | | | [table_Authors] 彭磊 ( 分析师 ) | 周明頔 ( 研究助理 ) | | | 010-83939806 | 010-83939792 | | | penglei018712@gtjas.com | zhoumingdi028698@gtjas.com | | 登记编号 | S0880518100003 | S0880123070156 | [Table_subIndustry] 细分行 ...

股 票 研 究 证 券 研 究 报 告 股票研究 /[Table_Date] 2024.09.09 国泰君安版权所有发送给上海东方财富金融数据服务有限公司.东财接收研报邮箱.ybjieshou@eastmoney.com p1 新股精要—国内领先的智能文字识别和商 业大数据领域产品服务商合合信息 本周新股发行信息 [table 益诺思（_NewStock] 688710.SH）发行 3524 万股 富特科技（301607.SZ）发行 2775 万股 | --- | --- | --- | --- | |----------|-------------------------------------|--------------------|--------------------------| | | | | —— IPO 专题 | | | [table_Authors] 王政之 ( 分析师 ) | 施怡昀 ( 分析师 ) | 王思琪 ( 分析师 ) | | | 021-38674944 | 021-38032690 | 021-38038671 | | | wangzhengzhi@gtjas.com | ...

Investment Rating - The report maintains a rating of "Buy" for Dongpeng Holdings [4][9]. Core Views - The company's 2024 interim report shows revenue of 3.094 billion yuan, a year-on-year decrease of 14.72%, and a net profit attributable to shareholders of 211 million yuan, down 45.22% year-on-year. The results are in line with expectations, considering the high base effect [9]. - The report highlights that the integrated channel is showing advantages, while cost control measures are continuously being implemented [3][4]. - Due to weak demand expected in 2024, the earnings per share (EPS) forecasts for 2024-2026 have been revised down to 0.52, 0.56, and 0.64 yuan respectively [9][10]. Summary by Sections Financial Performance - For the first half of 2024, tile revenue was 2.579 billion yuan, down 17% year-on-year, while bathroom revenue was 437 million yuan, up 5.22% year-on-year. The retail channel is under pressure, but the integrated channel is performing strongly with a 15.8% year-on-year increase [9]. - The overall gross margin for the first half of 2024 was 30.58%, a decrease of 1.45 percentage points year-on-year. The gross margin for tiles was 31.96%, down 1.50 percentage points, and for bathrooms, it was 21.66%, down 2.19 percentage points [9][10]. Market Outlook - The report anticipates that the competitive landscape will continue to pressure profitability, with a focus on optimizing cost structures. The company has successfully reduced tile manufacturing costs by 3.60% year-on-year [9][10]. - The target price has been adjusted to 7.80 yuan, down from the previous forecast of 9.29 yuan, reflecting the anticipated market conditions [4][9]. Valuation Metrics - The report provides a comparison of valuation metrics with peer companies, indicating that Dongpeng Holdings is trading at a lower price-to-earnings (PE) ratio compared to its peers, suggesting potential undervaluation [12].

股 票 研 究 公 司 更 新 报 告 证 券 研 究 报 告 国泰君安版权所有发送给上海东方财富金融数据服务有限公司.东财接收研报邮箱.ybjieshou@eastmoney.com p1 股票研究 /[Table_Date] 2024.09.09 ——泽璟制药公司跟踪点评 ZG006 临床数据亮眼，早研管线兑现加速 泽璟制药-U(688266) [Table_Industry] 医药/必需消费 | --- | --- | --- | --- | --- | --- | |----------|-----------------------------------|----------------------------|------------------------------|-------|-------| | | | | | | | | | [table_Authors] 丁丹 ( 分析师 ) | ( 分析师 ) | 姜铸轩 ( 分析师 ) | | | | | 0755-23976735 | 021-38675855 | 021-38674878 | | | | | dingdan@gtjas.c ...

国泰君安版权所有发送给上海东方财富金融数据服务有限公司.东财接收研报邮箱.ybjieshou@eastmoney.com p1 股 票 研 究 证 券 研 究 报 告 股票研究 /[Table_Date] 2024.09.09 ——家电补贴政策系列更新 补贴再加码，湖北先行已受益 [Table_Industry] 家用电器业 [Table_Invest] 评级： 增持 上次评级: 增持 家用电器业《多家公司发布中报业绩，家空外销 延续增长》2024.08.26 家用电器业《线上空调表现较好，铜铝价格环比 上升》2024.08.19 家用电器业《多家公司发布中报业绩，社零同比 涨幅扩大》2024.08.19 家用电器业《湖北率先补贴加码，托举家电零售 增长》2024.08.13 | --- | --- | --- | --- | --- | |----------|-------------------------------------|----------------------|--------------------|------------------------------------------- ...

Investment Rating - The report maintains a "Buy" rating for the company [4][6]. Core Views - The company's performance in the first half of 2024 exceeded market expectations, driven by rapid growth in smart power distribution orders and accelerated development in overseas distribution business [3][4]. - The earnings per share (EPS) forecasts for 2024 and 2025 have been raised to 1.71 and 2.10 CNY respectively, with a target price set at 44.55 CNY based on a price-to-earnings (PE) ratio of 21.21x for 2025 [4][6]. Financial Performance Summary - In H1 2024, the company achieved revenue of 6.997 billion CNY, a year-on-year increase of 26.11%, and a net profit attributable to shareholders of 1.150 billion CNY, up 32.23% year-on-year [4][5]. - The second quarter of 2024 saw revenue of 3.972 billion CNY, a 20.37% increase year-on-year and a 31.34% increase quarter-on-quarter [4]. - The company’s smart power distribution business generated revenue of 5.316 billion CNY in H1 2024, reflecting a 27.2% year-on-year growth, with net profit reaching 0.971 billion CNY, up 29.37% year-on-year [4]. Business Segment Performance - The smart power distribution business has a backlog of orders amounting to 14.894 billion CNY, a 25.74% increase year-on-year, with significant growth in overseas markets [4]. - The medical services segment reported revenue of 1.613 billion CNY in H1 2024, a 26.53% increase year-on-year, with a focus on rehabilitation services [4]. Financial Projections - The company’s projected revenues for 2024, 2025, and 2026 are 14.373 billion CNY, 17.634 billion CNY, and 20.887 billion CNY respectively, with corresponding net profits of 2.411 billion CNY, 2.964 billion CNY, and 3.569 billion CNY [5][12]. - The net asset return (ROE) is expected to improve from 17.3% in 2023 to 22.8% in 2026 [5][12].